Literature DB >> 16533973

A comparative study of primary and secondary hemifacial spasm.

Carlo Colosimo1, Matteo Bologna, Simona Lamberti, Laura Avanzino, Lucio Avanzino, Lucio Marinelli, Laura Marinelli, Giovanni Fabbrini, Giovanni Abbruzzese, Giovanni Defazio, Alfredo Berardelli.   

Abstract

BACKGROUND: Hemifacial spasm (HFS) is a common movement disorder.
OBJECTIVE: To evaluate possible differences in the demographic and clinical features between primary and secondary HFS.
DESIGN: In-person interview using a standardized questionnaire to collect demographic and clinical data.
SETTING: A multicenter study that included patients with HFS attending 3 Italian academic centers. Patients Two hundred fourteen patients with HFS. MAIN OUTCOME MEASURE: A complete neurological examination assessed the current muscle distribution of spasm and the presence of synkinetic movements between upper and lower facial muscles.
RESULTS: The study sample comprised 214 patients with HFS, 81 men and 133 women, having a mean +/- SD age of 65.9 +/- 12.3 years; 164 patients were classified as having primary HFS and 50 patients (48 postparalytic and 2 symptomatic cases) were classified as having secondary HFS. Patients with primary and those with secondary HFS had similar mean +/- SD ages at onset (54.9 +/- 13.5 vs 57.0 +/- 12.8 years), male-female ratios (63:101 vs 18:32), right-sided-left-sided HFS (77:86 [1 bilateral] vs 21:28 [1 bilateral]), and frequencies of familial cases (2.9% vs 2.0%), respectively. Most patients (65.0%) with primary HFS had initial symptoms of periocular muscle contractions alone and had subsequent involvement of the lower facial muscles. Most patients (72.0%) with secondary HFS reported initial involvement of the upper and lower facial muscles simultaneously. Signs of synkinesis were present in primary (43.3%) and secondary (58.0%) HFS.
CONCLUSIONS: Patients with primary and those with secondary HFS share common demographic and clinical features, including sex distribution, age at onset, affected side of HFS, synkinesis, and rarity of familial cases. Signs of synkinesis were present in significant proportions of patients with primary or secondary HFS. The 2 forms differed in clinical presentation.

Entities:  

Mesh:

Year:  2006        PMID: 16533973     DOI: 10.1001/archneur.63.3.441

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  21 in total

1.  Functional end-plate recovery in long-term botulinum toxin therapy of hemifacial spasm: a nerve conduction study.

Authors:  C Butera; R Guerriero; S Amadio; D Ungaro; H Tesfaghebriel; F Bianchi; G Comi; U Del Carro
Journal:  Neurol Sci       Date:  2012-02-25       Impact factor: 3.307

2.  Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.

Authors:  Libin Xiao; Yougui Pan; Xiaolong Zhang; Yong Hu; Li Cai; Zhiyu Nie; Lizhen Pan; Bing Li; Yijing He; Lingjing Jin
Journal:  Neurol Sci       Date:  2016-07-18       Impact factor: 3.307

3.  A charcot-marie-tooth type 1B kindred associated with hemifacial spasm and trigeminal neuralgia.

Authors:  James B Caress; James A Lewis; Clark W Pinyan; Victoria H Lawson
Journal:  Muscle Nerve       Date:  2019-04-08       Impact factor: 3.217

4.  Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport.

Authors:  Katja Kollewe; Bahram Mohammadi; Reinhard Dengler; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2010-05-01       Impact factor: 3.575

5.  Preoperative Evaluation of Patients with Hemifacial Spasm by Three-dimensional Time-of-Flight (3D-TOF) and Three-dimensional Constructive Interference in Steady State (3D-CISS) Sequence.

Authors:  J-M Jia; H Guo; W-J Huo; S-W Hu; F He; X-D Sun; G-J Lin
Journal:  Clin Neuroradiol       Date:  2015-03-21       Impact factor: 3.649

6.  Hemifacial spasm: clinical characteristics of 321 Indian patients.

Authors:  Amit Batla; Chanchal Goyal; Garima Shukla; Vinay Goyal; Achal Srivastava; Madhuri Behari
Journal:  J Neurol       Date:  2012-01-06       Impact factor: 4.849

7.  Hemifacial spasm secondary to vascular loop compression: a rare case report.

Authors:  Pratibha S Sharma; Atul P Sattur; Preetam B Patil; Kirty R Nandimath; Kruthika S Guttal; Krishna Burde
Journal:  Oral Radiol       Date:  2017-06-20       Impact factor: 1.852

Review 8.  Treatment of Blepharospasm/Hemifacial Spasm.

Authors:  Kemar E Green; David Rastall; Eric Eggenberger
Journal:  Curr Treat Options Neurol       Date:  2017-09-30       Impact factor: 3.598

Review 9.  Botulinum Toxin Treatment of Movement Disorders.

Authors:  Yasaman Safarpour; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2018-02-24       Impact factor: 3.598

10.  Spread of Muscle Spasms in Hemifacial Spasm.

Authors:  Antonella Conte; Marika Falla; Maria Concetta Diana; Matteo Bologna; Antonio Suppa; Andrea Fabbrini; Carlo Colosimo; Alfredo Berardelli; Giovanni Fabbrini
Journal:  Mov Disord Clin Pract       Date:  2014-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.